M.B.A, CCO, Prescient Medicine
Tim Kanter is the CCO of Prescient Medicine, a company focused on producing tools that target patient outcomes and management in two key areas – medication interaction and medication efficacy –including the validated genetic test designed to predict individual risk of opioid addiction, LifeKit® Predict. Tim has worked for major pharmaceutical and biopharmaceutical companies including Baxalta/Baxter, Novo Nordisk, and ALTANA Pharma in both US and global roles. Most recently, he consulted with a variety of companies in the preparation and launch of new products and initiatives within multiple therapeutic areas. Tim holds a BS from the University of Florida and an MBA from the University of South Florida.
Prescient Medicine is a predictive health intelligence company providing innovative testing solutions that offer deeper predictive insights so doctors can make more informed clinical decisions leading to better patient outcomes.